Cingulate (NASDAQ:CING) reported quarterly losses of $(0.36) per share.
Reported Late Thursday, Bionomics Appoints Spyridon “Spyros” Papapetropoulos As President And Chief Executive Officer
Bionomics Limited (NASDAQ:BNOX, ASX: BNO)))), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients
